Yukinori Ozaki - Concepedia

Author

Yukinori Ozaki

Toranomon Hospital ORCID

Also Known As

Aditya Bardia, Masaya Hattori, Ozaki Yukinori, Ozaki, Yukinori, Y Ozaki, Y. Ozaki, Yukinori Ozaki

146

Publications

808

Citations

H-Index

Concepts

All Affiliations

Toranomon Hospital Japanese Foundation For Cancer Research National Cancer Center Hospital East Showa University Aichi Cancer Center

About

Yukinori Ozaki is an author at Toranomon Hospital specializing in medicine, pathology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	95
2	Pathology	3	3	78
3	Pharmacology	3	3	83
4	Cancer Therapeutics	2	2	36
5	Clinical Trials	1	1	17

Yukinori Ozaki

Publications

429

Citations

H-Index

Page 1

	Year	Citations
Prognostic value of programmed death‐ligand 1 expression in patients with stage <scp>III</scp> colorectal cancer Shigehiro Koganemaru, Naoko Inoshita, Yuji Miura, Cancer Science	2017	53
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition Mitsuo Terada, Aki Ito, Yuichiro Kikawa, Breast Cancer	2023	53
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese Yuko Tanabe, Chikako Shimizu, Akinobu Hamada, Cancer Chemotherapy and Pharmacology Molecular NeurosciencePeripheral NervesMedicinePathologyNeuropathic Pain	2017	47
Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, ESMO Open	2018	33
Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B) Yukinori Ozaki, Junji Tsurutani, Toru Mukohara, European Journal of Cancer	2022	30
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin Sumito Saeki, Kohei Kumegawa, Yōko Takahashi, Breast Cancer Research	2023	28
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report Yukinori Ozaki, Junichi Shindoh, Yuji Miura, BMC Cancer	2017	24
Ewing sarcoma of the liver with multilocular cystic mass formation: a case report Yukinori Ozaki, Yuji Miura, Shigehiro Koganemaru, BMC Cancer	2015	20
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G) Daisuke Sakai, Hiroya Taniguchi, Naotoshi Sugimoto, European Journal of Cancer OncologyGastrointestinal OncologyMedicineColorectal CancerPathology	2020	19
Abstract PD1-03: A multicenter phase II study evaluating the efficacy of nivolumab plus paclitaxel plus bevacizumab triple-combination therapy as a first-line treatment in patients with HER2-negative metastatic breast cancer: WJOG9917B NEWBEAT trial Yukinori Ozaki, Toru Mukohara, Junji Tsurutani, Cancer Research Metastatic Breast CancerOncologyBreast OncologyPharmacologyClinical Trials	2020	17

Page 1